Charles Henderson - VP, Client Growth & New Business, RAPP
NEW YORK, NY --
Global Net Product Sales for PROCYSBI ® of $23.8 Million for Third Quarter 2014 PROCYSBI Revenue of $52.2 Million Reached Through September 2014 PROCYSBI Revenue Guidance of $65-$70 Million Maintained 2014 Cash Operating Expense Guidance Narrowed to $80-$85 Million
NOVATO, Calif., Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.